Abstract

REVIEW ON EBOLA VIRUS DISEASE

Mittal S. Patil*, Monika J. Patil, Neha S.Patil, Prof.H.P.Suryawanshi, Dr.S. P. Pawar,

ABSTRACT

Ebola virus disease (EVD) is an acute viral syndrome that presents with fever and an ensuing bleeding diathesis that is marked by high mortality in human and nonhuman primetes. Fatality rates are between 50% and 100%.Due to its lethal nature, this filo virus is classified as a biological class 4 pathogen.The natural reservoir of the virus is unknown. A variety of tests have proven to be specific and useful for Ebola virus identification. Patient who are able to mount an immune response to the virus will begin to recover in 7 to 10 days and start the period of prolonged convalescence. Supportive management of infected patients is the primary method of treatment, with particular attention to maintenance of hydration, circulatory volume, blood pressure, and the provision of supplemental oxygen. Since there is a no specific treatment outside of supportive management and palliative care, containment of this potentially lethal virus is paramount. In almost all outbreaks of EVD, the fatality rate among health care workers with documented infections was higher than that of non-health care workers.

Keywords: EBV: Ebola Virus Disease, hemorrhage, fever, deadly virus.